Astrazeneca (AZN) Net Income - Minority (2009)

Astrazeneca (AZN) posted quarterly Net Income - Minority of -$2.0 million for Q4 2009.

Astrazeneca (AZN) Net Income - Minority (2009) Analysis & Trends

Astrazeneca (AZN) has reported Net Income - Minority for 1 consecutive years, with -$2.0 million the latest figure, recorded in Q4 2009.

In Q4 2009, Net Income - Minority changed N/A year-over-year to -$2.0 million; the TTM figure through Dec 2009 stood at -$2.0 million (changed N/A YoY), while the FY2009 annual figure was -$2.0 million, changed N/A from the prior year.
Net Income - Minority came in at -$2.0 million for Q4 2009 at Astrazeneca.
The five-year high for Net Income - Minority was -$2.0 million in Q4 2009, with the low at -$2.0 million in Q4 2009.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Income - Minority (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn	-
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn	-
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn	-
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn	-
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn	-
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn	-
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn	-
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn	-
9	Novartis Ag	113.45 Bn	113.67 Bn	-	-
10	Biogen	30.87 Bn	26.59 Bn	1.82 Bn	-

Historic Data

Download Data

Date	Value
Dec 31, 2009	-2.00 Mn